Post your clinical trial on JoinClinicalTrials.com to reach thousands of viewer daily. Our Clinical Trial Listings have consistently proven to be an ...
Condition: Opioid Use Intervention: Sponsors: University of Florida; National Institute on Aging (NIA); US Department of Health and Human Services Recruiting
Conditions: SCI - Spinal Cord Injury; Incomplete Spinal Cord Injury Interventions: Device: Soterix Medical tsDCS stimulator; Other: Locomotor training Sponsors: University of Florida; National Institutes of Health (NIH); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Brooks Rehabilitation Recruiting
Conditions: Heavy Menstrual Bleeding; Menorrhagia; Uterine Fibroids Interventions: Drug: Levonorgestrel IUS; Drug: Tranexamic Acid Sponsors: Shannon K. Laughlin-Tommaso; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Recruiting
Condition: Breast Cancer Intervention: Procedure: Cardiac magnetic resonance (cardiac MRI) Sponsors: University of Florida; Ocala Royal Dames Recruiting
Condition: Prostate Cancer Interventions: Radiation: IMRT to 45 Gy; prostate bed proton boost of 21.6 CGE; Radiation: Proton (prostate bed) to 70.2 CGE; Radiation: IMRT to 45 Gy; proton boost to prostate bed to 25.2 CGE; Radiation: Proton to 66.6 CGE Sponsors: Proton Collaborative Group; University of Florida Health Recruiting
Conditions: Ductal Breast Carcinoma In Situ; HER2/Neu Positive Interventions: Biological: Granulocyte-Macrophage Colony-Stimulating Factor; Biological: Multi-epitope HER2 Peptide Vaccine H2NVAC; Procedure: Therapeutic Conventional Surgery Sponsors: Mayo Clinic; National Cancer Institute (NCI) Recruiting
Condition: Pulmonary Arterial Hypertension Intervention: Sponsors: University of Florida; National Heart, Lung, and Blood Institute (NHLBI); Mayo Clinic; Federal University of Health Science of Porto Alegre Recruiting
Conditions: Breast Adenocarcinoma; Estrogen Receptor Negative; HER2/Neu Negative; Progesterone Receptor Negative; Stage III Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer; Stage IV Breast Cancer; Triple-Negative Breast Carcinoma Interventions: Drug: Binimetinib; Other: Laboratory Biomarker Analysis; Biological: Pembrolizumab Sponsors: Mayo Clinic; National Cancer Institute (NCI) Recruiting
Conditions: Pain, Chronic; Prescription Drug Abuse (Not Dependent) Intervention: Sponsors: University of Florida; Florida Medical Malpractice Joint Underwriting Association Recruiting
Condition: Non-small Cell Lung Cancer Interventions: Radiation: Daily Stereotactic Body Radiotherapy; Radiation: Non-Daily Stereotactic Body Radiotherapy Sponsor: University of Florida Recruiting
Condition: Injuries, Spinal Cord Intervention: Device: Diaphragm pacing Sponsors: University of Florida; Brooks Rehabilitation; The Craig H. Neilsen Foundation Recruiting
Condition: Aggressive Childhood Behavior Interventions: Behavioral: Mental Health Enhanced Positive Behavioral Interventions and Supports (PBIS-MH); Behavioral: Racial/Ethnic Discrimination Interventions (RED) Sponsors: Medical University of South Carolina; National Institute on Minority Health and Health Disparities (NIMHD) Recruiting
Conditions: Estrogen Receptor Positive; HER2/Neu Negative; Recurrent Breast Carcinoma; Stage III Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer; Stage IV Breast Cancer Interventions: Procedure: Biopsy; Procedure: Biospecimen Collection; Other: Laboratory Biomarker Analysis Sponsors: Mayo Clinic; National Cancer Institute (NCI) Recruiting
Conditions: HER2 Positive Breast Carcinoma; Stage III Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer; Stage IV Breast Cancer Interventions: Drug: FASN Inhibitor TVB-2640; Other: Laboratory Biomarker Analysis; Drug: Paclitaxel; Biological: Trastuzumab Sponsors: Mayo Clinic; National Cancer Institute (NCI) Recruiting
Condition: Amyotrophic Lateral Sclerosis Interventions: Procedure: Videofluoroscopic Swallowing Study (VFSS); Procedure: High Resolution Manometry; Other: DIGEST; Other: Penetration Aspiration Scale; Other: Normalized Residue Ratio Scale; Device: Voluntary Peak Cough Flow Testing; Device: Iowa Oral Performance Instrument; Drug: Capsaicin Challenge; Device: Pulmonary Function Testing; Other: Eating Assessment Tool 10; Other: The Center for Neurologic Study Bulbar Function Scale Sponsors: University of Florida; National Institute of Neurological Disorders and Stroke (NINDS) Recruiting
Conditions: Breast Cancer; Lymph Node Mapping; Sentinel Lymph Node Biopsy Intervention: Combination Product: IC2000 and SPY-PHI Sponsor: Novadaq Technologies ULC, now a part of Stryker Recruiting
Conditions: Esophageal Varices; Liver Cirrhoses; Bleeding Esophageal Varices; Upper Gastrointestinal Bleeding Intervention: Drug: Octreotide Sponsors: Medical University of South Carolina; Ohio State University; University of Texas Southwestern Medical Center; University of Florida Health Recruiting
Condition: Barrett Esophagus Intervention: Device: Tethered Capsule Endomicroscopy (TCE) Sponsors: Massachusetts General Hospital; Columbia University; Mayo Clinic; Kansas City Veteran Affairs Medical Center; National Institutes of Health (NIH); National Cancer Institute (NCI) Recruiting
Condition: Lung Cancer Interventions: Radiation: Standard Radiation Dose Therapy; Drug: cisplatin; Drug: etoposide; Radiation: High Radiation Dose Therapy; Drug: carboplatin Sponsors: Alliance for Clinical Trials in Oncology; National Cancer Institute (NCI) Recruiting
Condition: Carotid Stenosis Interventions: Procedure: Carotid endarterectomy (CEA); Device: Carotid Stenting (CAS); Other: Intensive Medical Management - no CEA; Other: Intensive Medical Management - no CAS Sponsors: Thomas G. Brott, M.D.; National Institute of Neurological Disorders and Stroke (NINDS) Recruiting
Condition: Prostate Cancer Interventions: Radiation: Standard of Care IMRT (Photon); Radiation: Standard of Care Proton Therapy; Radiation: Proton Arm 1: Standard Proton Therapy; Radiation: Proton Arm 2: Hypofractionated Proton Therapy Sponsors: University of Florida; Patient-Centered Outcomes Research Institute Recruiting
Condition: Coronary Artery Disease Interventions: Drug: High dose potent statin; Drug: ACE-I (lisinopril) or ARB (losartan); Drug: Aspirin; Behavioral: Lifestyle Counseling; Behavioral: Quality of Life Questionnaires Sponsors: University of Florida; United States Department of Defense Recruiting
Conditions: Gliosarcoma; Recurrent Glioblastoma Intervention: Procedure: Dynamic Susceptibility Contrast-Enhanced Magnetic Resonance Imaging Sponsors: ECOG-ACRIN Cancer Research Group; National Cancer Institute (NCI) Recruiting
Condition: Breast Carcinoma Interventions: Other: Health Education Program; Other: Weight Loss Intervention Sponsors: Alliance for Clinical Trials in Oncology; National Cancer Institute (NCI); Division of Cancer Control; NIH Biomarker, Imaging and Quality of Life Studies Funding Program (BIQSFP); Canadian Cancer Trials Group Recruiting
Condition: Brain and Central Nervous System Tumors Interventions: Drug: concomitant temozolomide (TMZ); Radiation: radiotherapy; Drug: procarbazine; Drug: adjuvant temozolomide (TMZ); Drug: CCNU; Drug: vincristine Sponsors: Alliance for Clinical Trials in Oncology; National Cancer Institute (NCI); European Organisation for Research and Treatment Center (EORTC); Canadian Cancer Trials Group Recruiting
Conditions: Early Onset Alzheimer Disease; Alzheimer Disease; Mild Cognitive Impairment Interventions: Drug: Flortaucipir; Drug: Florbetaben Sponsors: Liana Apostolova; Alzheimer's Therapeutic Research Institute; National Institute on Aging (NIA); Alzheimer's Association Recruiting
Conditions: Clear Cell Renal Cell Carcinoma; Metastatic Clear Cell Renal Cell Carcinoma; Stage III Renal Cell Cancer AJCC v8; Stage IV Renal Cell Cancer AJCC v7; Unresectable Renal Cell Carcinoma Interventions: Drug: Ascorbic Acid; Drug: Pazopanib Hydrochloride Sponsors: Academic and Community Cancer Research United; National Cancer Institute (NCI) Recruiting
Condition: Prostate Cancer Interventions: Radiation: Proton Beam Therapy; Radiation: Intensity Modulated Radiation Therapy Sponsors: Massachusetts General Hospital; University of Pennsylvania; National Cancer Institute (NCI); Northwestern Medicine Chicago Proton Center; ProCure Proton Therapy Center; Washington University School of Medicine; University of Washington; Rutgers Cancer Institute of New Jersey; Provision Center for Proton Therapy; Mayo Clinic; University of Maryland, College Park; University Hospitals Cleveland Medical Center; University of Florida Proton Therapy Institute Recruiting
Conditions: Estrogen Receptor Negative; HER2 Positive Breast Carcinoma; HER2/Neu Negative; Invasive Breast Carcinoma; Progesterone Receptor Negative; Stage I Breast Cancer AJCC v7; Stage IA Breast Cancer AJCC v7; Stage IB Breast Cancer AJCC v7; Stage II Breast Cancer AJCC v6 and v7; Stage IIA Breast Cancer AJCC v6 and v7; Stage IIB Breast Cancer AJCC v6 and v7; Triple-Negative Breast Carcinoma Interventions: Radiation: External Beam Radiation Therapy; Other: Laboratory Biomarker Analysis; Other: Quality-of-Life Assessment; Other: Questionnaire Administration; Radiation: Whole Breast Irradiation Sponsors: M.D. Anderson Cancer Center; National Cancer Institute (NCI) Recruiting
Conditions: Loss of Chromosome 17p; Recurrent Plasma Cell Myeloma Interventions: Drug: Dexamethasone; Drug: Idasanutlin; Drug: Ixazomib Citrate; Other: Laboratory Biomarker Analysis; Other: Pharmacological Study Sponsors: Mayo Clinic; National Cancer Institute (NCI) Recruiting
Condition: Metastatic Breast Cancer Interventions: Drug: LY3295668 Erbumine; Drug: Endocrine therapy; Drug: Midazolam Sponsor: Eli Lilly and Company Recruiting
Conditions: Pancreatic Cancer; Cancer Cachexia Interventions: Other: Blood Sample Collection; Other: Tumor Sample collection; Other: Data Collection Sponsor: H. Lee Moffitt Cancer Center and Research Institute Recruiting
Conditions: Cerebral Vein Thrombosis; Deep Vein Thrombosis; Malignant Neoplasm; Metastatic Malignant Neoplasm; Pulmonary Embolism; Splanchnic Vein Thrombosis Intervention: Drug: Apixaban Sponsors: Academic and Community Cancer Research United; National Cancer Institute (NCI) Recruiting
Conditions: ALK-Positive Large B-Cell Lymphoma; Atypical Burkitt/Burkitt-Like Lymphoma; Burkitt-Like Lymphoma With 11q Aberration; Diffuse Large B-Cell Lymphoma Activated B-Cell Type; Diffuse Large B-Cell Lymphoma Associated With Chronic Inflammation; Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type; Diffuse Large B-Cell Lymphoma, Not Otherwise Specified; EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified; EBV-Positive Mucocutaneous Ulcer; High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements; High Grade B-Cell Lymphoma, Not Otherwise Specified; Human Herpesvirus 8-Positive Neoplastic Cells Present; Intravascular Large B-Cell Lymphoma; Large B-Cell Lymphoma With IRF4 Rearrangement; Plasmablastic Lymphoma; Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type; Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System; Primary Effusion Lymphoma; Recurrent B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma; Recurrent B-Cell Non-Hodgkin Lymphoma; Recurrent Burkitt Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Lymphomatoid Granulomatosis; Recurrent Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma; Refractory B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma; Refractory B-Cell Non-Hodgkin Lymphoma; Refractory Burkitt Lymphoma; Refractory Diffuse Large B-Cell Lymphoma; Refractory Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma; Small Intestinal High Grade B-Cell Lymphoma, Not Otherwise Specified; T-Cell/Histiocyte-Rich Large B-Cell Lymphoma Interventions: Biological: Nivolumab; Drug: Varlilumab Sponsor: National Cancer Institute (NCI) Recruiting
Condition: Chronic Heart Failure With Preserved Systolic Function Interventions: Drug: Dapagliflozin 10Mg Oral Tablet; Drug: Dapagliflozin matching placebo Sponsor: Saint Luke's Health System Recruiting